something to ponderAnd this is how even biotech analysts who know a lot about the biotech space, technology, and companies, can get it wrong and be blindsided with great and unexpected news ... sound familiar? ;)
| 31-Dec-20 13:53 ET | In Play | Small cap notable movers of interest
BNGO (2.91 +38.59%): Continued strength on above 11x average volume; the stock has now spiked by more than +300% over the past week. Recent press for co included its announcement last week of the publication of a study by the Human Genome Structural Variation Consortium revealing that their sequencing method based on PacBio HiFi reads detected only 72% of the large SVs that co's optical genome mapping detected across 32 different human genomes. Co also recently announced that Praxis Genomics, which uses optical genome mapping with co's Saphyr System, received accreditation from the College of American Pathologists; co believes that the accreditation is "a key step on the path to reimbursement of Saphyr-based LDTs by third party payors." |